HCA
EVH icon

Harbor Capital Advisors’s Evolent Health EVH Stock Holding History

Harbor Capital Advisors’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$175K Sell
32,288
-10,747
-25% -$41.2K 0.01% 625
2026
Q1 		$98K Buy
+43,035
New +$137K 0.01% 645
2025
Q1 		– Sell
-803,211
Closed -$9.04M – 1451
2024
Q4 		$9.04M Buy
803,211
+380,790
+90% +$6.69M 0.39% 73
2024
Q3 		$11.9M Buy
422,421
+246,400
+140% +$6.35M 0.52% 44
2024
Q2 		$3.37M Buy
176,021
+140,357
+394% +$3.58M 0.26% 102
2024
Q1 		$1.17M Sell
35,664
-23,757
-40% -$758K 0.15% 175
2023
Q4 		$1.96M Sell
59,421
-9,235
-13% -$261K 0.38% 67
2023
Q3 		$1.87M Buy
68,656
+8,108
+13% +$225K 0.4% 58
2023
Q2 		$1.83M Buy
+60,548
New +$1.96M 0.37% 62

Other funds holding EVH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RPA
Rock Point Advisors Burlington, Vermont $409M AUM 30.68% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $243M AUM 9.84% 1-Year Est. Return
BSP
Benefit Street Partners New York $69.6M AUM

Harbor Capital Advisors's EVH Position: Q2 2026 in Review

Harbor Capital Advisors reduced its Evolent Health (EVH) stake by 25% in Q2 2026, selling an estimated $41.2K and leaving 32,288 shares worth $175K. The position accounts for 0.01% of the portfolio, ranked #625.

Harbor Capital Advisors first reported a position in EVH in Q2 2023 and has held it in 9 quarters since. The position peaked at $11.9M in Q3 2024. 81 funds tracked by Wall St. Rank hold EVH as of Q2 2026.

  • Harbor Capital Advisors held 32,288 shares of Evolent Health worth $175K as of Q2 2026.
  • Harbor Capital Advisors sold 10,747 Evolent Health shares in Q2 2026, an estimated $41.2K.
  • Evolent Health made up 0.01% of Harbor Capital Advisors's portfolio in Q2 2026, its #625 holding.
  • Harbor Capital Advisors first reported a position in Evolent Health in Q2 2023 and has held it in 9 quarters since.
  • Harbor Capital Advisors's Evolent Health position peaked at $11.9M in Q3 2024.
  • 81 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.

Based on Harbor Capital Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.